Alembic Ltd

₹ 118 -0.42%

11 Jul 9:17 a.m.

alembiclimited.com BSE: 506235 NSE: ALEMBICLTD

About

Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL became the flagship company of the Alembic Group.
With its registered office in Vadodra, Alembic Ltd currently holds a 28.41% stake in Alembic Pharma Ltd and a 19.01% stake in another group entity Paushak Limited.^[1]

Key Points

Business Segments
A) Real Estate (~80% in FY24 vs 59% in FY22): ^[1] ^[2] The company is involved in the construction of residential & commercial real estate projects. It also leases commercial properties. ^[3] Real Estate business experienced strong growth between FY23-FY24 bolstered by strong demand and higher property prices. ^[4]

Website BSE NSE

Market Cap ₹ 3,031 Cr.
Current Price ₹ 118
High / Low ₹ 169 / 85.5
Stock P/E 9.80
Book Value ₹ 91.1
Dividend Yield 2.03 %
ROCE 6.90 %
ROE 13.7 %
Face Value ₹ 2.00

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Company is expected to give good quarter
Company has been maintaining a healthy dividend payout of 24.1%
Company's working capital requirements have reduced from 87.5 days to 63.7 days

Cons

Tax rate seems low
Company has a low return on equity of 11.6% over last 3 years.
Earnings include an other income of Rs.74.9 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Consumer Discretionary Realty Realty Residential, Commercial Projects

Part of BSE SmallCap BSE Allcap BSE Consumer Discretionary

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	18	22	37	31	37	37	32	39	49	51	53	58	60
	15	17	26	20	24	26	22	28	25	30	33	32	33
Operating Profit	3	5	11	10	13	11	10	12	24	20	20	26	27
OPM %	16%	25%	30%	34%	36%	30%	31%	30%	49%	40%	37%	46%	45%
	4	1	59	2	-9	3	48	2	2	2	66	4	3
Interest	0	0	0	0	0	0	0	0	0	0	1	1	1
Depreciation	1	2	2	2	2	2	2	3	1	2	3	3	3
Profit before tax	6	4	68	11	3	12	56	11	24	19	82	27	27
Tax %	20%	11%	10%	2%	-55%	14%	8%	9%	12%	10%	6%	5%	12%
	1	-19	115	46	48	44	91	61	72	56	121	65	68
EPS in Rs	0.04	-0.72	4.49	1.78	1.88	1.73	3.53	2.39	2.81	2.17	4.71	2.55	2.67
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2010	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	1,121	144	134	147	125	124	74	74	78	127	157	222
	1,018	134	128	140	114	106	71	62	64	87	101	128
Operating Profit	103	10	6	7	11	18	3	11	14	40	57	94
OPM %	9%	7%	5%	5%	9%	15%	4%	15%	18%	32%	36%	42%
	16	21	25	25	37	29	93	10	89	54	55	75
Interest	32	1	0	0	0	0	0	0	0	0	1	2
Depreciation	43	6	6	5	4	3	3	4	5	7	8	11
Profit before tax	44	23	25	27	44	45	93	17	98	87	103	156
Tax %	10%	-3%	2%	-3%	5%	8%	0%	19%	12%	7%	10%	7%
	40	107	235	145	163	213	329	343	222	191	269	311
EPS in Rs	1.48	3.99	8.78	5.45	6.10	8.30	12.82	13.35	8.65	7.42	10.46	12.10
Dividend Payout %	17%	4%	2%	4%	3%	2%	5%	2%	21%	30%	23%	20%

Compounded Sales Growth
10 Years:	4%
5 Years:	25%
3 Years:	42%
TTM:	41%

Compounded Profit Growth
10 Years:	11%
5 Years:	-1%
3 Years:	12%
TTM:	16%

Stock Price CAGR
10 Years:	12%
5 Years:	8%
3 Years:	18%
1 Year:	-14%

Return on Equity
10 Years:	15%
5 Years:	12%
3 Years:	12%
Last Year:	14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2010	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	27	53	53	53	53	51	51	51	51	51	51	51
Reserves	311	474	750	858	1,032	1,157	1,367	2,246	2,445	2,027	2,134	2,287
	408	0	9	0	0	0	0	0	0	0	9	14
	251	91	64	81	73	57	53	112	135	127	134	150
Total Liabilities	997	619	875	992	1,159	1,266	1,471	2,409	2,632	2,205	2,329	2,503
	393	169	146	171	179	209	225	265	297	321	369	409
CWIP	4	2	0	0	0	0	3	6	0	0	1	0
Investments	8	299	605	732	913	1,001	1,133	2,047	2,208	1,754	1,786	1,900
	591	149	124	89	67	55	110	91	127	130	173	194
Total Assets	997	619	875	992	1,159	1,266	1,471	2,409	2,632	2,205	2,329	2,503

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2010	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	149	22	10	52	24	22	7	-2	-18	39	23	86
	-24	5	-5	-47	-22	68	57	-35	19	7	26	-27
	-118	-25	-5	-5	-3	-89	-6	-15	-6	-46	-48	-58
Net Cash Flow	7	2	-0	-0	-1	1	57	-52	-5	-0	0	1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2010	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	63	122	76	54	74	40	44	69	71	67	46	49
Inventory Days	158	880	659	438	247	289	411	2,112	2,885		3,694
Days Payable	128	200	144	128	125	202	151	693	640		1,237
Cash Conversion Cycle	93	801	591	364	195	126	305	1,488	2,316	67	2,502	49
Working Capital Days	108	235	172	39	20	13	22	98	223	118	81	64
ROCE %	10%		4%	4%	4%	4%	7%	1%	4%	4%	5%	7%

Shareholding Pattern

Numbers in percentages

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%
	1.08%	0.83%	0.82%	0.70%	0.72%	0.85%	0.89%	1.07%	1.42%	1.97%	1.78%	1.65%
	4.29%	4.12%	3.94%	3.94%	3.93%	3.40%	0.04%	0.04%	0.04%	0.08%	0.06%	0.05%
	23.75%	24.16%	24.34%	24.48%	24.46%	24.87%	28.17%	28.02%	27.66%	27.07%	27.27%	27.41%
No. of Shareholders	83,006	83,612	83,630	82,339	81,732	82,947	94,012	99,130	98,478	1,02,249	1,07,423	1,06,732

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	65.77%	63.71%	64.57%	67.62%	70.88%	70.88%	70.88%	70.88%	70.88%
	5.60%	1.16%	1.04%	1.80%	1.60%	1.12%	0.70%	1.07%	1.65%
	0.09%	5.35%	5.81%	5.94%	4.34%	4.69%	3.94%	0.04%	0.05%
	0.00%	0.67%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	28.54%	29.11%	28.58%	24.64%	23.18%	23.31%	24.48%	28.02%	27.41%
No. of Shareholders	56,623	66,838	61,605	53,132	67,238	80,135	82,339	99,130	1,06,732

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Alembic Ltd

Alembic Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings